Vivo Capital » Investment News
62 FOLLOWERS
This section of the blog features articles on Healthcare Investment. Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies. Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development and commercial stage products. Since inception, the firm has approximately $5.8 billion in..
Vivo Capital » Investment News
2d ago
Categories
All News
Portfolio News
Vivo News
The post Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion in Cash, Leveraging Povetacicept for IgA Nephropathy and Autoimmune Diseases appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
1M ago
Categories
All News
Portfolio News
Vivo News
The post VISEN Announces Acceptance of a Biologics License Application for Lonapegsomatropin in China appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
1M ago
Categories
All News
Portfolio News
Vivo News
The post Evaheart Launches EVA-Pulsar™, Second Generation Destination Therapy Left Ventricular Assist Device (LVAD) Treating Heart Failure Patients appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
1M ago
Categories
All News
Portfolio News
Vivo News
The post Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
3M ago
Categories
All News
Portfolio News
Vivo News
The post Beijing oncology biotech Avistone raises $140M Series B for commercialization in China, expansion into US appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
3M ago
Categories
All News
Portfolio News
Vivo News
The post Vivo Capital invests in Createrna appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
3M ago
Categories
All News
Portfolio News
Vivo News
The post Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
3M ago
Categories
All News
Portfolio News
Vivo News
The post Visirna doses first patient in pivotal study in Chinese adult patients with familial chylomicronemia syndrome (FCS) appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
3M ago
Categories
All News
Portfolio News
Vivo News
The post EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Officer and President, Extends Series A Financing to Over $70 Million appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more
Vivo Capital » Investment News
3M ago
Categories
All News
Portfolio News
Vivo News
The post Bristol Myers Squibb secures RayzeBio in $4.1 billion deal, adding premier radiopharmaceutical platform appeared first on Vivo Capital | Healthcare Focused Investment Firm ..read more